#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pseudomyxoma peritonei Palmoplantar pustulosis Glomerulonephritis Gastrooesophageal cancer Breast angiosarcoma metastatic Lennox-Gastaut syndrome Brain injury Round cell liposarcoma Primary biliary cholangitis Conjunctivitis allergic NTRK gene fusion overexpression Cholangitis sclerosing Carcinoid tumour Acute respiratory distress syndrome Hodgkin's disease recurrent More trials…

    Learn about Rare Diseases

    Synovial sarcoma metastatic – Diagnostics Alagille syndrome – Treatment Choroid melanoma Ehlers-Danlos syndrome – Diagnostics Pulmonary fibrosis – Trials in Disease Primary biliary cholangitis – Diagnostics Leiomyosarcoma recurrent – Treatment Ornithine transcarbamoylase deficiency – Treatment Progressive supranuclear palsy – Treatment Congenital hypotransferrinaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nnc0194-0499 Zongertinib Thiocolchicoside Desflurane Magnesium Oxybate Crisantaspase Ethambutol Furosemide Tozinameran Idelalisib Solifenacin Succinate Bms-986458 OLVEREMBATINIB Aup1602-C Tepotinib Prasugrel Temocillin Ulipristal Acetate Valsartan Indapamide More therapies…

    Learn about Your Condition

    Dyspnoea Vomiting Hypomagnesaemia Prostate cancer Vestibular disorder Malignant melanoma stage II Perthes disease Idiopathic pulmonary fibrosis Infectious pleural effusion Hypertrophic scar Immunosuppression Kidney transplant rejection Extra-osseous Ewing's sarcoma Intestinal obstruction Mitral valve prolapse More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Muscle spasticity

  • Comparison of Pregabalin and Baclofen Treatment in Patients with Spastic Motor Behavior Following Cervical or Thoracic Spinal Cord Injury

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Baclofen
    • Pregabalin
    Czechia

  • Study on the Safety and Effectiveness of IPN10200 for Treating Upper Limb Spasticity in Adults After Stroke or Brain Injury

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    • Clostridium Botulinum, Neurotoxin Serotype A/B
    Austria Bulgaria Czechia France Germany Hungary +4

  • Study on Botulinum Toxin Type A for Treating Spastic Equinovarus in First-Time Stroke Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    Belgium

  • Study on Riluzole for Reducing Spasticity in Patients with Chronic Spinal Cord Injury

    Recruiting

    3 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Cellulose, Microcrystalline
    • Riluzole
    France

  • Study of individualized doses of botulinum toxin type A (incobotulinumtoxin) in adults with severe spasticity caused by brain damage

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Spain

  • Study comparing Dry Needling and Botulinum Toxin Type A treatments for leg muscle stiffness in stroke patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Botulinum Toxin Type A
    Belgium Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!